Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CDC expects COVID and RSV levels to increase in coming weeks
Reuters
Wednesday, November 20, 2024 - 8:36pm
tags:
CDC, RSV, COVID-19
Novo, Viking heat up MASH space with promising data at AASLD24
BioSpace
Wednesday, November 20, 2024 - 11:40am
tags:
Novo Nordisk, Viking Therapeutics, MASH, AASLD, GLP-1 agonists, semaglutide, VK2809
Pfizer, under pressure to change, names oncology head as new R&D chief
BioPharma Dive
Wednesday, November 20, 2024 - 11:33am
tags:
Pfizer, R&D, oncology, Chris Boshoff
Biotechs go big for bitcoin: Trio of companies each plan to stash $1M as reserve
Fierce Biotech
Wednesday, November 20, 2024 - 11:32am
tags:
Bitcoin, cryptocurrency, Donald Trump, biotech, Acurx Pharmaceuticals, Hoth Therapeutics
Weight-loss drug coverage rises among largest US employers, Mercer survey finds
MSN/Reuters
Wednesday, November 20, 2024 - 11:30am
tags:
employers, coverage, insurance, weight loss, obesity
23andMe, Mirador enter strategic research collaboration
Tip Ranks
Wednesday, November 20, 2024 - 11:28am
tags:
23andMe, Mirador, R&D, data, precision medicine
What might a Trump administration mean for the Biosecure Act?
Pharma Voice
Wednesday, November 20, 2024 - 11:27am
tags:
Donald Trump, Biosecure Act, China
Sage wilts as Huntington's prospect flunks trial
Pharmaphorum
Wednesday, November 20, 2024 - 11:25am
tags:
SAGE Therapeutics, clinical trials, dalzanemdor, Huntington's disease
Roche files patent suit to fend off potential Evrysdi generics from Zydus, Natco
Fierce Pharma
Wednesday, November 20, 2024 - 11:24am
tags:
Roche, Evrysdi, generics, SMA, patents, Zydus, Natco
Pfizer, Flagship return to obesity as part of latest additions to multibillion-dollar collaboration
Fierce Biotech
Wednesday, November 20, 2024 - 11:22am
tags:
Pfizer, Flagship Pioneering, obesity, drug development
Drugmakers and pharmacists battle over who gets to make obesity drugs
NPR
Wednesday, November 20, 2024 - 11:21am
tags:
Novo Nordisk, Eli Lilly, obesity, weight loss, GLP-1 agonists, compounded drugs
FDA shares additional draft guidance on cell and gene therapy
Clinical Trials Arena
Wednesday, November 20, 2024 - 11:20am
tags:
FDA, regulatory, gene therapy, cell therapy
Pfizer loses bid to recoup $75 million left over from SEC settlement
MSN/Reuters
Tuesday, November 19, 2024 - 7:19pm
tags:
Pfizer, legal, SEC, insider trading
Medtronic lifts annual profit view on steady demand for medical devices
Yahoo/Reuters
Tuesday, November 19, 2024 - 7:15pm
tags:
Medtech, Medtronic, earnings
England's NICE turns down cancer drug Enhertu—again—amid pricing stalemate with AZ, Daiichi Sankyo
Fierce Pharma
Tuesday, November 19, 2024 - 7:14pm
tags:
AstraZeneca, Daiichi Sankyo, Enhertu, UK, NICE
Trump nominates Dr. Oz to lead Centers for Medicare and Medicaid Services
Medical Marketing and Media
Tuesday, November 19, 2024 - 7:12pm
tags:
Dr. Oz, Donald Trump, CMS, Medicare, Medicaid
Incyte sinks on setback for drugs acquired in $750M buyout
BioPharma Dive
Tuesday, November 19, 2024 - 7:10pm
tags:
Incyte, Escient Pharma, M&A
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Yahoo/Benzinga
Tuesday, November 19, 2024 - 7:09pm
tags:
Bristol Myers Squibb, ACR, clinical trials, autoimmune disease
Prostate cancer: Three drug trials to watch
Clinical Trials Arena
Tuesday, November 19, 2024 - 11:22am
tags:
prostate cancer, clinical trials, Candel Therapeutics, ProstAtak, JNJ, Akeega, Pfizer, Mevrometostat
Bayer lands regional rights to aficamten in Japan deal with Cytokinetics
First Word Pharma
Tuesday, November 19, 2024 - 11:20am
tags:
Bayer, Japan, Cytokinetics, aficamten, hypertrophic cardiomyopathy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.